eCQM: Chlamydia Screening for Women (CMS 153v5)


Chlamydia Screening for Women


CMS 153v5

Measure Type:


MIPS High Priority Measure:


Quality ID:


Eligible for Quality Programs:

  • Merit-Based Incentive Payment System (MIPS)
  • Medicaid EHR Incentive Program (Meaningful Use)

Performance Benchmark for MIPS:



Percentage of women 16-24 years of age who were identified as sexually active and who had at least one test for chlamydia during the measurement period.

  • Numerator: Women with at least one chlamydia test during the measurement period.
  • Denominator: Women 16 to 20 and 20 to 24 years of age who are sexually active and who had an eligible visit (defined as chart notes with one of the following encounter types: Office Visit, Nursing Home Visit, Nurse Visit or Home Visit) during the measurement period.
    • Denominator Exclusions: Women who are only eligible for the initial population due to a pregnancy test and who had an x-ray or an order for a specified medication within 7 days of the pregnancy test.

    • Denominator Exceptions: None

eCQM Patient Reports

eCQM Patient Reports can help you identify patient care gaps and improve the performance of your quality measures. Click on the blue result numbers in the eCQM Dashboard to see the patient report for this measure.

The eCQM Patient Reports list the individual patients included in the measure’s population, which measure cohorts the patient is in, and contact information for the patient to streamline any downstream communication that may be needed to fulfill the measure requirements. You can choose to print the patient list for a measure or export it as a CSV.

The measure cohorts included in the eCQM Patient Report for CMS 153v5 Chlamydia Screening for Women are:

  • Initial patient population
  • Denominator
  • Numerator
  • Exclusion

Practice Fusion Suggested Workflow
Practice Fusion suggests the following workflow to help ensure that you are able to meet the requirements of this measure within the Practice Fusion EHR.

  1. For all visits with female patients age 16-24 years of age, determine if she is sexually active as defined by the measure and ensure the correct data identifying her as such is entered in the medical record.

    1. Examples of diagnosis codes and lab tests that identify sexually active patients can be found in Table 1.

  2. For female patients who are deemed to be sexually active as defined by the measure, ensure that she has received a chlamydia test during the measurement period or ensure that a chlamydia test is completed.

  3. Once the chlamydia test is completed, receive or record structured lab results for Pap Smear or Chlamydia Screening tests in the Practice Fusion EHR.

    1. Pap Smear and Chlamydia Screening Test codes that will be included in this measure when manually recording structured lab results in the Practice Fusion EHR or when receiving structured lab results from connected labs can be found in Table 1.

Table 1: Examples of Coded Values that can be recorded for CMS 153v5

Data Type

Example Codes

Diagnosis Codes that identify Sexually Active Patients

  • Z34.92 (ICD-10)
  • A60.03 (ICD-10)
  • A54.24 (ICD-10)
  • B20 (ICD-10)
  • A56.02 (ICD-10)
  • A63.0 (ICD-10)

Lab Tests that identify Sexually Active Patients

  • Treponema pallidum IgM Ab [Presence] in Serum by Immunofluorescence (LOINC 17729-5)
  • Reagin Ab [Presence] in Serum by RPR (LOINC 20507-0)

Procedures that identify Sexually Active Patients

  • Insertion of subcutaneous contraceptive (procedure)
  • Fitting of cervical cap (procedure)

Medication Orders that identify Sexually Active Patients

  • Ethinyl Estradiol 0.01 MG Oral Tablet (RXNORM 248310)
  • Levonorgestrel 0.00354 MG/HR Drug Implant (RXNORM 1366343)

Pap Smear Test Codes

  • Microscopic observation [Identifier] in Cervix by Cyto stain (LOINC 10524-7)
  • General categories [Interpretation] of Cervical or vaginal smear or scraping by Cyto stain (LOINC 19762-4)

Chlamydia Screening Test Codes

  • Chlamydia trachomatis [Presence] in Unspecified specimen by Organism specific culture (LOINC 6349-5)
  • Chlamydia trachomatis rRNA [Presence] in Cervix by Probe and target amplification method (LOINC 50387-0)
To access a complete list of the qualifying data for this measure, visit the United States Health Information Knowledgebase (USHIK). This site is produced by the Agency for Healthcare Research and Quality (AHRQ) in partnership with CMS and the National Library of Medicine (NLM). A free Unified Medical Language System® (UMLS) license, available from NLM, is required to access USHIK.

Additional Measure Information

  • This 2016 measure version has been updated from the previous 2015 version specifications, incorporating the following change:

    • Clarified the description of the denominator exclusions.

    • Added a sentence in the guidance to clarify who was eligible for the denominator  exclusion.

    • Added logic to match the guidance for the denominator exclusion.

  • To be recognized for the denominator exclusion, the patient must have the appropriate diagnosis code, X-ray, or medication order recorded in her chart. Women who receive a pregnancy test solely as a safety precaution before ordering an X-ray or specified medications are also excluded from this measure. Please ensure that the pregnancy test and the associated x-ray are recorded in the patient chart if a patient should be excluded.

    • Please note that the denominator exclusion does not apply to patients who qualify for the denominator based on services other than the pregnancy test alone. These other services include services for sexually transmitted infections, contraceptives or contraceptive devices and infertility treatments.

More Information


  1. How does the eCQM Dashboard work?
  2. How​ ​do​ ​I​ ​create​ ​a​ ​group​ ​in​ ​the​ ​eCQM​ ​Dashboard?
  3. eCQM Depression Remission at Twelve Months (CMS159v5)
  4. eCQM: Initiation and Engagement of Alcohol and Other Drug Dependence Treatment (CMS137v5)
  5. eCQM: Preventive Care and Screening: Screening for Depression and Follow-Up Plan (CMS 2v6)
  6. eCQM: Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented (CMS 22v5)
  7. eCQM: Closing the Referral Loop: Receipt of Specialist Report (CMS 50v5)
  8. eCQM: Documentation of Current Medications in the Medical Record (CMS 68v6)
  9. eCQM: Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-up Plan (CMS 69v5)
  10. eCQM: Functional Status Assessments for Congestive Heart Failure (CMS 90v6)
  11. eCQM: Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) (CMS 122v5)
  12. eCQM: Diabetes: Foot Exam (CMS 123v5)
  13. eCQM: Cervical Cancer Screening (CMS 124v5)
  14. eCQM: Breast Cancer Screening (CMS 125v5)
  15. eCQM: Pneumococcal Vaccination Status for Older Adults (CMS 127v5)
  16. eCQM: Colorectal Cancer Screening (CMS 130v5)
  17. eCQM: Diabetes: Eye Exam (CMS 131v5)
  18. eCQM: Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention (CMS 138v5)
  19. eCQM: Falls: Screening for Future Fall Risk (CMS 139v5)
  20. eCQM: Preventive Care and Screening: Influenza Immunization (CMS 147v6)
  21. eCQM: Dementia: Cognitive Assessment (CMS 149v5)
  22. eCQM: Chlamydia Screening for Women (CMS 153v5)
  23. eCQM: Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents (CMS 155v5)
  24. eCQM: Use of High-Risk Medications in the Elderly (CMS 156v5)
  25. eCQM: Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antiplatelet (CMS 164v5)
  26. eCQM: Controlling High Blood Pressure (CMS 165v5)
  27. eCQM: Use of Imaging Studies for Low Back Pain (CMS 166v6)

Feedback and Knowledge Base